ONESOURCE — Onesource Specialty Pharma Income Statement
0.000.00%
Last trade - 00:00- IN₹231.77bn
- IN₹237.78bn
- IN₹14.45bn
Annual income statement for Onesource Specialty Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | PRESS |
| Standards: | IAS | IAS | — |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 387 | 1,719 | 14,449 |
| Cost of Revenue | |||
| Gross Profit | -17.8 | 813 | 10,098 |
| Selling / General / Administrative Expenses | |||
| Depreciation and Amortization | |||
| Unusual Expense / Income | |||
| Other Operating Expenses | |||
| Total Operating Expenses | 4,003 | 4,460 | 13,631 |
| Operating Profit | -3,616 | -2,741 | 818 |
| Gain / Loss on Sale of Assets | |||
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | -4,156 | -3,657 | -671 |
| Provision for Income Taxes | |||
| Net Income After Taxes | -4,156 | -3,657 | -173 |
| Net Income Before Extraordinary Items | |||
| Extraordinary Items | |||
| Net Income | -7,998 | -3,912 | -180 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | -7,998 | -3,912 | -180 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -23.6 | -21.3 | 4.97 |
| Dividends per Share |